Downregulation of HORMAD1 in SCCs cancer cells sensitized them to etoposide treatment and may sensitize HORMAD1 dependent cells/tumors to other chemotherapy treatments, as demonstrated in studies involving breast and lung adenocarcinoma models [27,28,29]. The gene discussed is HORMAD1; the disease is cancer.